All articles by Vijay Madhukar Singavarapu

  1. M&As this week: Tabula Rasa, Generex, Flex Pharmaceuticals

    Tabula Rasa HealthCare has completed the acquisition of DoseMe. DoseMe’s advanced precision dosing tool DoseMeRx™ and Tabula’s Medication Risk Mitigation (MRM)…
    Read More…

    11 Jan
  2. Deals this week: Keros Therapeutics, Opollomics, CANbridge

    Keros Therapeutics has raised $23m in a series B funding round. Existing investors Pontifax, Arkin Bio Ventures, Partners Innovation Fund, and…
    Read More…

    11 Jan
  3. M&As this week: MabSpace Biosciences, Cambrex, Hetero Labs

    MabSpace Biosciences has merged with HJB to create a fully-integrated biotherapeutics company named Transcenta Holding. Transcenta will have more than…
    Read More…

    4 Jan
  4. Deals this week: Antengene Corporation, Acer Therapeutics, Menarini

    Antengene Corporation has raised $120m in a series B funding round led by Boyu Capital and FountainVest. The funding round…
    Read More…

    4 Jan
  5. Deals this week: DelSiTech, Marken, Erasca

    DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV) therapeutics. Innovare will make upfront…
    Read More…

    21 Dec
  6. M&As this week: 10x Genomics, Atlantic Research Group, AGC

    10x Genomics has acquired Spatial Transcriptomics to enter the field of spatial genomics. The acquisition will enable 10x Genomics to gain…
    Read More…

    14 Dec
  7. Deals this week: Moderna, Oxford Biotherapeutics, CBT Pharmaceuticals

    Moderna has priced its initial public offering (IPO) of 26 million common stock shares at $23 a share, with the aim…
    Read More…

    14 Dec
  8. Deals this week: Argenx, SmartZyme BioPharma, Viracta Therapeutics

    Argenx will develop and license its cancer drug candidate cusatuzumab (ARGX-110) after partnering with Janssen Pharmaceutical’s affiliate company Cilag International. The two…
    Read More…

    7 Dec
  9. Deals this week: Nuformix, Fluidic Analytics, F2G Biotech

    Nuformix has expanded its agreement with Newsummit Biopharma (NSB) for the licensing and commercialisation of cancer drug NXP001. Nuformix will…
    Read More…

    30 Nov
  10. M&As this week: LGC, Akseera Pharma, Wayland Group

    LGC aims to bolster its position in the clinical quality control tools market with its acquisition of SeraCare Life Sciences. The deal…
    Read More…

    30 Nov

Go Top